“LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab Ozogamicin in AML”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 12, no. 1, Apr. 2020, p. e2020020, https://doi.org/10.4084/mjhid.2020.020.